SERVICES – PRODUCTION

Currently, our orders are processed through our warehouses in Heidelberg and the Netherlands. We have guaranteed production capacity through our warehouse in Heidelberg. We can deliver up to 1.5 million rapid tests per month. Additionaly, we have long-term contracts with manufacturers who have transferred their capacities to MEXACARE GmbH. Our partner companies have additional capacities of 1.5 to 4.5 million tests per month. Also, we can generate further capacities through our network. Our current production capacity is 100 million tests p.a. and is expandable, depending on order volume.

SERVICES – QUALITY

We demand the highest standards from our products. Our quality meets the specific German/European standards and certifications – such as CE mark, ISO 13485:2016 – approved by the US Food and Drug Administration (FDA), Canada Health Sciences, and Australian Health Authority. Furthermore, our products comply with the European Directive for In-vitro Diagnostics (IVDD 98/79/EC). Leading laboratories and research institutions in the diagnostic field in Europe, North America, and Australia validate the achievement of these high-quality standards.

In detail: Each product batch is extensively tested to ensure the best quality for your delivery. The raw materials are thoroughly analyzed and checked, and the finished products are tested with appropriate control materials and measuring instruments. Finally- the certificate of analysis is issued.

SERVICES – CONSULTING

With decades of successful expertise in all areas of strategic business, product development, manufacturing, and international commercialization, MEXACARE supports pharmaceutical and diagnostic companies that are also active in gene expression profiling, differential diagnostics, and laboratory diagnostics. For more than 30 years, our team has been working with various, extremely competent and successful ex-Quidel top managers and company founders in the „biotech nucleus California“, who, through the Windarmere Venture Partners, have founded about 40 companies.

One of these companies, Prometheus Laboratories, which due to its unique „Rx/Dx Business Model“, represents a new „gold standard“ in the diagnosis of and individualized therapy for Chronic Inflammatory Bowel Disease (IBD) in the USA. As a result, Prometheus Laboratories has become the fastest-growing life science company in the USA (Inc Magazine – „The Inc 500“ and Deloitte & Touche Fast 50 Competition).

Further affiliated companies, in which we are or were active in management or as consultants, are the start-up Proprius Pharmaceuticals (sold to Cypress Bioscience) as well as acting as consultants for Metrika and AviaraDx.
Due to our extensive contacts in diagnostics and various pharmaceutical fields on both sides of the Atlantic, MEXACARE sees itself as experienced management consultants to our clients. We accompany the top management in strategic decisions: innovation management, the realization of market and expansion strategies, and the development and evaluation of portfolio strategies.

SERVICES – LOGISTICS

  • MODERN LOGISTICS FACILITY FOR IN-TIME DELIVERY

  • MANY YEARS OF EXPERIENCE IN LOGISTICS WITH MEDICAL PRODUCTS

  • COOPERATION WITH PHARMACEUTICAL WHOLESALERS

  • ISO-CERTIFIED

  • PACKAGING

  • OVERNIGHT DELIVERY

WRITE TO US

DO YOU HAVE QUESTIONS ABOUT OUR PRODUCTS
OR NEED ADVICE? WE ARE HERE FOR YOU!

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.